IDO1 and depressive symptom measurement: When IDO1 increases or inflammation induces hyperactivation, more tryptophan becomes metabolized into kynurenine, leading to tryptophan depletion and insufficient synthesis of 5-HT, which affects the function of both the cerebral cortex and hippocampus, inducing depression-like behaviors such as loss of interest and insomnia [50].